ANIXA BIOSCIENCES, INC. (ANIX) Debt Components
- 2017-07-31: Secured Debt, CurrentUSD $2.00M; Notes Payable, CurrentUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
- 2017-04-30: Secured Debt, CurrentUSD $3.00M; Notes Payable, CurrentUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
- 2017-01-31: Secured Debt, CurrentUSD $3.00M; Notes Payable, CurrentUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
- 2016-11-30: Secured Debt, CurrentUSD (m); Notes Payable, CurrentUSD (m); Long-term DebtUSD (m); Long-term Debt, GrossUSD (m).
ANIXA BIOSCIENCES, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Secured Debt, Current USD | Notes Payable, Current USD | Long-term Debt USD | Long-term Debt, Gross USD | Debt Instrument, Face Amount USD | Long-term Debt, Fair Value USD | Debt Instrument, Interest Rate, Stated Percentage pure | Debt Instrument, Convertible, Beneficial Conversion Feature USD | Debt Instrument, Convertible, Conversion Price USD/shares | Debt Instrument, Convertible, Threshold Trading Days pure | Debt Instrument, Unamortized Discount USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-07-31 | $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-04-30 | $3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-01-31 | $3.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-11-30 | (m) | (m) | (m) | (m) | $3.50M | (m) | (m) | (m) | (m) | (m) | $-2.09M |
| 2016-10-31 | (m) | $468.76K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | $370.18K | (m) | $1.76M | (m) | (m) | (m) | (m) | (m) | $-1.39M |
| 2015-10-31 | (m) | $380.76K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-10-31 | (m) | (m) | $370.18K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.57M | (m) | (m) | (m) |
| 2014-10-31 | (m) | (m) | (m) | $2.45M | $1.44M | (m) | (m) | (m) | (m) | (m) | $891.40K |
| 2014-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $1.57M | (m) | (m) | (m) |
| 2014-07-31 | (m) | (m) | (m) | $2.45M | $1.44M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $1.57M | (m) | (m) | (m) |
| 2014-04-30 | (m) | (m) | (m) | $2.45M | $1.44M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 3 month · $1.57M | (m) | (m) | (m) |
| 2014-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) | (m) | (m) | (m) |
| 2013-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 0.19 | (m) | (m) |
| 2013-11-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.09M |
| 2013-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $1.18M | (m) | (m) | (m) |
| 2013-10-31 | (m) | (m) | (m) | $259.85K | $325.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $891.40K |
| 2013-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $1.18M | (m) | (m) | (m) |
| 2013-07-31 | (m) | (m) | (m) | $259.85K | $325.00K | (m) | (m) | (m) | (m) | (m) | $989.43K |
| 2013-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $1.18M | (m) | (m) | (m) |
| 2013-04-30 | (m) | (m) | (m) | (m) | $970.00K | $1.76M | (m) | (m) | 0.15 | (m) | (m) |
| 2013-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 1 month · 1000.00% | (m) |
| 2013-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) | (m) | (m) | (m) |
| 2013-01-31 | (m) | (m) | (m) | (m) | $1.76M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-01-25 | (m) | (m) | (m) | (m) | $370.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $717.73K |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | 8.00% | (m) | 0.09 | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |